Washout gradient in dynamic contrast-enhanced MRI is associated with tumor aggressiveness of prostate cancer

Journal of Magnetic Resonance Imaging

Volumn 36, Issue 4, 2012, Pages 912-919

  Chen, Yu Jen ^a   Chu, Woei Chyn ^a   Pu, Yeong Shiau ^b   Chueh, Shih Chieh ^b   Shun, Chia Tung ^b   Tseng, Wen Yih Isaac ^b,c  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

diffusion tensor imaging (DTI); dynamic contrast enhanced MRI (DCE MRI); Gleason score (GS); magnetic resonance imaging (MRI); prostate cancer (PCA)

Indexed keywords

CONTRAST MEDIUM; GADOLINIUM PENTETATE; SCOPOLAMINE BUTYL BROMIDE;

ADULT; AGED; APPARENT DIFFUSION COEFFICIENT; ARTICLE; CANCER LOCALIZATION; CANCER PATIENT; CANCER TISSUE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DENSITY GRADIENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFUSION COEFFICIENT; DIFFUSION TENSOR IMAGING; DISEASE SEVERITY; DYNAMIC CONTRAST ENHANCED MAGNETIC RESONANCE IMAGING; ECHOGRAPHY; GLEASON SCORE; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PATHOPHYSIOLOGY; PERFUSION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; QUANTITATIVE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; WASHOUT GRADIENT;

AGED; ALGORITHMS; CONTRAST MEDIA; GADOLINIUM DTPA; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84866396440     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.23723     Document Type: Article

References (32)

1. Buhmeida A, Pyrhonen S, Laato M, Collan Y,. Prognostic factors in prostate cancer. Diagn Pathol 2006; 1: 4.
2. Epstein JI, Amin M, Boccon-Gibod L, et al. Prognostic factors and reporting of prostate carcinoma in radical prostatectomy and pelvic lymphadenectomy specimens. Scand J Urol Nephrol Suppl 2005: 34-63
3. Noworolski SM, Vigneron DB, Chen AP, Kurhanewicz J,. Dynamic contrast-enhanced MRI and MR diffusion imaging to distinguish between glandular and stromal prostatic tissues. Magn Reson Imaging 2008; 26: 1071-1080.
4. deSouza NM, Riches SF, Vanas NJ, et al. Diffusion-weighted magnetic resonance imaging: a potential non-invasive marker of tumour aggressiveness in localized prostate cancer. Clin Radiol 2008; 63: 774-782.
5. Gleason DF,. Classification of prostatic carcinomas. Cancer Chemother Rep 1966; 50: 125-128.
6. Epstein JI, Allsbrook WC Jr, Amin MB, Egevad LL,. The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surg Pathol 2005; 29: 1228-1242. (Pubitemid 41232997)
7. Haider MA, van der Kwast TH, Tanguay J, et al. Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer. AJR Am J Roentgenol 2007; 189: 323-328. (Pubitemid 47195916)
8. Reischauer C, Wilm BJ, Froehlich JM, et al. High-resolution diffusion tensor imaging of prostate cancer using a reduced FOV technique. Eur J Radiol 2011; 80: e34-41.
9. Shimofusa R, Fujimoto H, Akamata H, et al. Diffusion-weighted imaging of prostate cancer. J Comput Assist Tomogr 2005; 29: 149-153. (Pubitemid 40411296)
10. deSouza NM, Reinsberg SA, Scurr ED, Brewster JM, Payne GS,. Magnetic resonance imaging in prostate cancer: the value of apparent diffusion coefficients for identifying malignant nodules. Br J Radiol 2007; 80: 90-95. (Pubitemid 46951251)
11. Tamada T, Sone T, Jo Y, et al. Apparent diffusion coefficient values in peripheral and transition zones of the prostate: comparison between normal and malignant prostatic tissues and correlation with histologic grade. J Magn Reson Imaging 2008; 28: 720-726.
12. Chen YJ, Pu YS, Chueh SC, Shun CT, Chu WC, Tseng WY,. Diffusion MRI predicts transrectal ultrasound biopsy results in prostate cancer detection. J Magn Reson Imaging 2011; 33: 356-363.
13. Padhani AR, Gapinski CJ, Macvicar DA, et al. Dynamic contrast enhanced MRI of prostate cancer: correlation with morphology and tumour stage, histological grade and PSA. Clin Radiol 2000; 55: 99-109. (Pubitemid 32054531)
14. Kozlowski P, Chang SD, Jones EC, Berean KW, Chen H, Goldenberg SL,. Combined diffusion-weighted and dynamic contrast-enhanced MRI for prostate cancer diagnosis-correlation with biopsy and histopathology. J Magn Reson Imaging 2006; 24: 108-113.
15. Yoshizako T, Wada A, Hayashi T, et al. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer. Acta Radiol 2008; 49: 1207-1213.
16. Franiel T, Hamm B, Hricak H,. Dynamic contrast-enhanced magnetic resonance imaging and pharmacokinetic models in prostate cancer. Eur Radiol 2010; 21: 616-626.
17. Fuchsjager M, Shukla-Dave A, Akin O, Barentsz J, Hricak H,. Prostate cancer imaging. Acta Radiol 2008; 49: 107-120.
18. Padhani AR, Husband JE,. Dynamic contrast-enhanced MRI studies in oncology with an emphasis on quantification, validation and human studies. Clin Radiol 2001; 56: 607-620. (Pubitemid 35023779)
19. Jager GJ, Ruijter ET, van de Kaa CA, et al. Dynamic TurboFLASH subtraction technique for contrast-enhanced MR imaging of the prostate: correlation with histopathologic results. Radiology 1997; 203: 645-652. (Pubitemid 27227409)
20. Engelbrecht MR, Huisman HJ, Laheij RJ, et al. Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR imaging. Radiology 2003; 229: 248-254. (Pubitemid 37152132)
21. Tofts PS, Brix G, Buckley DL, et al. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 1999; 10: 223-232. (Pubitemid 29463104)
22. Ocak I, Bernardo M, Metzger G, et al. Dynamic contrast-enhanced MRI of prostate cancer at 3 T: a study of pharmacokinetic parameters. AJR Am J Roentgenol 2007; 189: 849.
23. Kozlowski P, Chang SD, Meng R, et al. Combined prostate diffusion tensor imaging and dynamic contrast enhanced MRI at 3T-quantitative correlation with biopsy. Magn Reson Imaging 2010; 28: 621-628
24. Kinkel K, Helbich TH, Esserman LJ, et al. Dynamic high-spatial-resolution MR imaging of suspicious breast lesions: diagnostic criteria and interobserver variability. AJR Am J Roentgenol 2000; 175: 35-43. (Pubitemid 30415534)
25. Sherif H, Mahfouz AE, Oellinger H, et al. Peripheral washout sign on contrast-enhanced MR images of the breast. Radiology 1997; 205: 209-213. (Pubitemid 27415150)
26. Erbersdobler A, Isbarn H, Dix K, et al. Prognostic value of microvessel density in prostate cancer: a tissue microarray study. World J Urol 2010; 28: 687-692.
27. Kurhanewicz J, Vigneron D, Carroll P, Coakley F,. Multiparametric magnetic resonance imaging in prostate cancer: present and future. Curr Opin Urol 2008; 18: 71-77 (Pubitemid 350307535)
28. Alonzi R, Padhani AR, Allen C,. Dynamic contrast enhanced MRI in prostate cancer. Eur J Radiol 2007; 63: 335-350. (Pubitemid 47321040)
29. Padhani AR, Khoo VS, Suckling J, Husband JE, Leach MO, Dearnaley DP,. Evaluating the effect of rectal distension and rectal movement on prostate gland position using cine MRI. Int J Radiat Oncol Biol Phys 1999; 44: 525-533. (Pubitemid 29258426)
30. Steinberg DM, Sauvageot J, Piantadosi S, Epstein JI,. Correlation of prostate needle biopsy and radical prostatectomy Gleason grade in academic and community settings. Am J Surg Pathol 1997; 21: 566-576. (Pubitemid 27213072)
31. King CR, McNeal JE, Gill H, Brooks JD, Srinivas S, Presti JC Jr,. Reliability of small amounts of cancer in prostate biopsies to reveal pathologic grade. Urology 2006; 67: 1229-1234. (Pubitemid 43818080)
32. Tsao J, Hansen MS, Kozerke S,. Accelerated parallel imaging by transform coding data compression with k-t SENSE. Conf Proc IEEE Eng Med Biol Soc 2006; 1: 372. (Pubitemid 46519876)